Please assess the completion status of the following clinical trial:

Trial Title: Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Female with an intact uterus with lifetime history of 0-4 sexual partners~Exclusion Criteria:~* Prior Human Papillomavirus (HPV) vaccination~* Prior abnormal paps~* History of genital warts

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 23 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): V501
- 2 (Type: PLACEBO_COMPARATOR): Placebo
- 3 (Type: EXPERIMENTAL): HPV 16 Monovalent Vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).